The Economics of Healthcare- Blood Cancer - CLL Support

CLL Support

22,526 members38,689 posts

The Economics of Healthcare- Blood Cancer

otonal profile image
3 Replies

This popped up on Twitter as a sponsored link. It's worth reading

janssen-emea.com/sites/defa...

Written by
otonal profile image
otonal
To view profiles and participate in discussions please or .
3 Replies
AussieNeil profile image
AussieNeilAdministrator

Excellent points - surely policy makers need to know the TOTAL lifetime costs of all available options so the best decisions are possible?

For CLL, that approach would also highlight the dire need for more research and clinical trials into ways to reduce the impact of CLL and CLL treatments on our immunity.

NeIl

virdieblue profile image
virdieblue

So many issues go into cost/benefit analysis. Make my head spin. Is Ibrutinib a bargain because I am not hospitalized?...

Virginia

otonal profile image
otonal in reply to virdieblue

It puzzles me that innovations are always said to cost more, even when it means that less time is spent at the hospital.

You may also like...

Chicken link to blood cancer

leave it and if it helps just one person, then it’s worth it. I can only add one photo to a post...

Pfizer Vaccine and Blood Cancer

window for cancer patients, and particularly for blood cancer,...

COVID, Pneumonia and healthcare

recent experience with COVID-19, pneumonia, and healthcare. I tested positive for COVID 20 days ago...

Healthcare in Canada and UK

Blood cancers debate in UK Parliament - CLL highlighted

fairer access for patients with blood cancers (rarer cancers). You can read the full debate here:...